NCT03079518View on ClinicalTrials.gov

Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

March 10, 2017

Primary Completion Date

October 25, 2017

Study Completion Date

October 25, 2017

Conditions
Heart Failure, SystolicIron Deficiency
Interventions
DRUG

Ferric Carboxymaltose

single shot infusion

OTHER

blood withdrawal

for determination of serum and urinary biomarkers of chronic kidney disease metabolism and other parameters

Trial Locations (1)

52074

Department of Medicine, Division of Cardiology, Pulmonary Diseases and Vascular Medicine at the University Hospital, RWTH Aachen, Aachen

All Listed Sponsors
lead

RWTH Aachen University

OTHER

NCT03079518 - Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency | Biotech Hunter | Biotech Hunter